| HOME >> BIOLOGY >> TECHNOLOGY |
Net Income (Loss) $(0.39) $(0.27) $1.83 $1.28
Diluted Earnings (Loss) per
Share:(1)
Income (Loss) From
Continuing Operations $(0.52) $(0.25) $1.66 $1.26
Income (Loss) on
Discontinued Operations 0.13 (0.01) 0.13 -
Cumulative Effect of
Accounting Change - (0.01) - (0.01)
Net Income (Loss) $(0.39) $(0.27) $1.79 $1.25
Weighted Average Shares
Outstanding:(1)
Basic 545.1 542.8 544.1 540.0
Diluted 545.1 542.8 555.0 551.6
Monsanto Company
Selected Financial Information
(Dollars in millions)
Unaudited Condensed Statements of Consolidated Financial As of As of
Position Aug. 31, Aug. 31,
2007 2006 Assets
Current Assets:
Cash and Cash Equivalents $866 $1,460
Trade Receivables - Net of Allowances of
$217 and $298, respectively 1,499 1,455
Miscellaneous Receivables 407 344
Deferred Tax Assets 449 390
Inventories 1,719 1,688
Other Current Assets 144 124
Total Current Assets 5,084 5,461
Property, Plant and Equipment - Net 2,656 2,418
Goodwill 2,625 1,522
Other Int
'/>"/>
| SOURCE Monsanto Copyright©2007 PR Newswire. All rights reserved |